CPT 82731: Fetal Fibronectin Semiquantitative Analysis

Headline: CPT code 82731 enables semiquantitative fetal fibronectin testing for preterm birth risk assessment

Lead: CPT code 82731 identifies the technical laboratory procedure that measures fetal fibronectin levels in cervicovaginal secretions using a semiquantitative method. This diagnostic assay informs clinical assessment of preterm birth risk and guides perinatal management decisions.

CPT code 82731 captures the laboratory-based, technical component of a fetal fibronectin assay. Nationally, standardized reporting of this code supports consistency in perinatal risk stratification and laboratory billing for obstetric providers and diagnostic labs. Payors commonly included in national analyses are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find: an explanation of the clinical purpose of the assay, the typical laboratory setting and service type, and the contexts in which semiquantitative fetal fibronectin results are used in obstetric risk assessment. The publication summarizes common billing pathways, relevant modifiers when reported by payers, and benchmarking considerations for laboratory technical components. It also outlines clinical context that frames when this test is clinically relevant to prenatal care and preterm birth risk evaluation.

This summary is written for a national audience of clinicians, billing professionals, and policy analysts seeking a clear description of CPT code 82731 and its role in perinatal diagnostic testing.

Billing Code Overview

CPT code 82731 describes a technical laboratory assay that performs a semiquantitative analysis of fetal fibronectin in cervicovaginal secretions. The service is a laboratory diagnostic test that assesses the amount of fetal fibronectin present in a pregnant patient's cervicovaginal sample.

Service type: Laboratory diagnostic testing (technical component)
Typical site of service: Clinical laboratory or hospital laboratory receiving cervicovaginal specimens for analysis

Data not available in the input.

Clinical Context

A 29-year-old pregnant patient at 30 weeks' gestation presents to the obstetrics clinic with complaints of increased pelvic pressure and irregular uterine contractions. Vital signs are stable; fetal heart tones are reassuring. The clinician performs a sterile speculum exam and collects a cervicovaginal swab for fetal fibronectin testing to assess the risk of spontaneous preterm birth. The specimen is sent to the clinical laboratory where a lab analyst performs the technical assay corresponding to 82731, producing a semiquantitative result reported to the ordering provider. Based on the test result and the patient’s clinical presentation, the obstetric team documents counseling and determines next steps in triage, monitoring, or transfer to higher-level care.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component if separated from the technical lab work.
`TC`	Technical component	Use when billing only the laboratory technical component; commonly appended when the lab performs the assay and the ordering clinician does not report a professional component.

Taxonomy Code	Specialty	Notes
`207V00000X`	Obstetrics & Gynecology	Ordering clinicians who evaluate pregnant patients and collect specimens.
`207R00000X`	Maternal-Fetal Medicine	Specialists managing high-risk pregnancy and interpreting risk assessments.
`3352A0200X`	Clinical Laboratory	Laboratory professionals and directors overseeing testing and reporting.
`208D00000X`	Family Medicine	Primary care providers who may order the test in prenatal care settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`O60.1`	Preterm labor with preterm delivery	Positive fetal fibronectin is associated with increased risk of preterm labor and delivery.
`O60.0`	Preterm labor without delivery	Test used to risk-stratify patients presenting with symptoms of preterm labor.
`O09.89`	Supervision of other high-risk pregnancy	Used when fetal fibronectin assists management in high-risk pregnancies.
`O20.9`	Hemorrhage in early pregnancy, unspecified	Included when vaginal bleeding prompts evaluation for preterm birth risk.
`Z3A.30`	Weeks of gestation 30 completed weeks	Gestational age codes commonly accompany testing to document timing of assessment.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`51702`	Measurement of post-void residual urine; bladder scan, noninvasive	Not directly related; Data not available in the input.
`76815`	Ultrasound, pregnant uterus, real time for fetal and maternal evaluation, limited	Often performed alongside `82731` when contractions or preterm labor are suspected to assess cervical length and fetal status.
`59425`	Antepartum care only; 4 or more visits	Represents broader antepartum management during which `82731` may be ordered for symptomatic patients.
`88112`	Cytopathology, cervical or vaginal (eg, Pap) with manual screening	Performed in gynecologic evaluation; may be part of concurrent sample collection but not directly linked to fetal fibronectin testing.
`99000`	Handling and/or conveyance of specimen for transfer to another facility	Used when specimens for `82731` are transported to a reference lab.

OpenPayer

Summary & Overview